Authors
Latest:
Comorbidities Can Affect CML Treatment DecisionsThere are certain comorbidities and lifestyle factors that practitioners must consider before prescribing treatment for chronic myelogenous leukemia.
Latest:
Higher Breast Density Found in Women Who Received Hormonal Fertility TreatmentWomen with a history of infertility, and have undergone hormonal fertility treatment have denser breast tissue, which may increase their risk of developing breast cancer, according to a study published in the journal Breast Cancer Research.
Latest:
Dr. Hirshfield Discusses Screening Patients for Genetic MutationsKim M. Hirshfield, MD, PhD, medical oncologist, Stacy Goldstein Breast Cancer Center, Rutgers Cancer Institute of New Jersey, discusses selecting individuals to screen for genetic mutations and the challenges of better selecting patients to screen.
Latest:
Sexual Health in Survivorship: Simple Solutions Can Follow Speaking UpOne of the most commonly-affected areas of life impacted by disease and treatment
Latest:
4 Ways to Help Patients With Metastatic Lung Cancer Find Meaning in Their ExperiencesOncology nurses can help patients with metastatic lung cancer find meaning in their experiences and potentially help them cope more effectively with their diagnosis.
Latest:
When You Hear Hoof Beats, Think ZebrasDiagnosing and treating a patient with a less common cancer can be challenging for practitioners, yet with greater awareness and better diagnostics more of these rare cancers are likely to show up in the clinic.
Latest:
Seeing Cancer Through a Sibling's Eyes: What We Don't Know Can Hurt ThemFrom the University of Pennsylvania School of Nursing: Healthy siblings of children with cancer should not be overlooked in family-centered care.
Latest:
American Breast Cancer FoundationThe American Breast Cancer Foundation's (ABCF) mission is to provide financial assistance for breast cancer screenings and diagnostic tests for uninsured and underserved individuals, regardless of age or gender.
Latest:
Forged Through Fire: Nurses Are More Needed Than Ever BeforeGreat men and women are forged through fire, so people who are passionate about health care should not put a nursing degree on hold because of the COVID-19 pandemic.
Latest:
Searching for Prognostic Markers in Patients with OsteosarcomaTo extend the quality of life for patients with osteosarcoma, researchers are looking for ways to identify before chemo whether or not they need that treatment.
Latest:
Biden Cancer Initiative Names Cancer Support Community CEO Kim Thiboldeaux to Board of DirectorsThe Biden Cancer Initiative has named Kim Thiboldeaux, the CEO of Cancer Support Community, to its Board of Directors.
Latest:
Lisa Carey on Minimizing Interventions for Breast Cancer TreatmentLisa Carey, MD, professor of medicine, University of North Carolina at Chapel Hill, discusses the need to minimize interventions for breast cancer treatment.
Latest:
Women in Appalachia Need Support to Optimize Their Adjuvant Breast Cancer TherapyA new study has uncovered notable disparities in uptake of adjuvant breast cancer therapies in the Appalachian region of the United States, suggesting targeted intervention strategies may help to improve outcomes for this population of women.
Latest:
Danielle Crump on Alternatives to Anesthesia for Pediatric Radiation PatientsDanielle Crump, BSN, RN, discusses alternatives to administering anesthesia for pediatric patients undergoing radiation therapy.
Latest:
Implementing CheckMate-227 Data in the PracticeWith plenty of data from the CheckMat-227 trial to go through, one expert breaks down the vital data that will directly impact the practice.
Latest:
Prostate Cancer Diagnoses Decrease With Lenient Screening RecommendationsAfter the USPSTF advised against prostate cancer screening for all men, there was a decrease in the incidence of the disease.
Latest:
Examining CIPN's Effects on Daily LivesChemotherapy-induced periphreal neuropathy can affect patients' daily living, and some individuals may be more prone to it than others.
Latest:
Improving Glycemic Control in Individuals With Cancer and DiabetesIt is estimated that 8%-18% of all cancer patients will have preexisting diabetes at the time they are diagnosed with cancer.
Latest:
Oncology Drug Crash Course: Lenvatinib (Lenvima) for Advanced Endometrial CancerLenvatinib is approved in combination with pembrolizumab for the treatment of patients with advanced endometrial cancer who have disease progression after systemic therapy, are not candidates for curative surgery or radiation, and who are mismatch repair proficient or not microsatellite instability–high.
Latest:
Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric CancerShared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
Latest:
Antibiotic Overuse During COVID-19 Pandemic Exacerbates Need for Firmer Prescription Policies, Expert SaysThe reality of the COVID-19 pandemic will force lawmakers to firmly act on behalf of antibiotic policies, according to an expert with Pew Charitable Trusts.
Latest:
Your Workforce Should Reflect Your CommunityDiversity, equity, and inclusion must be a centerpiece of nursing recruitment and retention.
Latest:
Johanna Garibaldi On Strengthening Cancer Prevention Tactics With Mobile Screening ClinicsJohanna Garibaldi, BSN, RN, EMT-P, discusses how a mobile clinic improved cancer screening rates among local firefighters.
Latest:
Insights on Evolving Treatment Strategies for Multiple MyelomaThe panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Latest:
Jessica MacIntyre on Improving LLS Referrals For Patients With Hematologic MalignanciesJessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, discusses ways to standardize the process of referring patients to the Leukemia and Lymphoma Society.
Latest:
Unmet Needs and Future Perspectives on the treatment of R/R MMExperts provide advice for patients and caregivers with relapsed/refractory multiple myeloma considering talquetamab or another bispecific, while all faculty will discuss unmet needs and future perspectives in the treatment of relapsed/refractory multiple myeloma.
